CSL.AX
CSL Ltd
Price:  
247.98 
AUD
Volume:  
684,962.00
Australia | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CSL.AX WACC - Weighted Average Cost of Capital

The WACC of CSL Ltd (CSL.AX) is 8.4%.

The Cost of Equity of CSL Ltd (CSL.AX) is 9.10%.
The Cost of Debt of CSL Ltd (CSL.AX) is 4.45%.

Range Selected
Cost of equity 7.90% - 10.30% 9.10%
Tax rate 18.60% - 19.20% 18.90%
Cost of debt 4.00% - 4.90% 4.45%
WACC 7.3% - 9.4% 8.4%
WACC

CSL.AX WACC calculation

Category Low High
Long-term bond rate 4.0% 4.5%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.77 0.86
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.90% 10.30%
Tax rate 18.60% 19.20%
Debt/Equity ratio 0.16 0.16
Cost of debt 4.00% 4.90%
After-tax WACC 7.3% 9.4%
Selected WACC 8.4%

CSL.AX's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for CSL.AX:

cost_of_equity (9.10%) = risk_free_rate (4.25%) + equity_risk_premium (5.60%) * adjusted_beta (0.77) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.